共 50 条
- [42] Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice JOURNAL OF PHYSIOLOGY-LONDON, 2010, 588 (17): : 3217 - 3229
- [49] Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
- [50] Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study FRONTIERS IN NEUROLOGY, 2022, 13